John C. McKew

2021

In 2021, John C. McKew earned a total compensation of $1.4M as President and Chief Scientific Officer at NewLink Genetics, a 15% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$262,500
Option Awards$420,881
Salary$490,308
Stock Awards$170,703
Other$52,176
Total$1,396,568

McKew received $490.3K in salary, accounting for 35% of the total pay in 2021.

McKew also received $262.5K in non-equity incentive plan, $420.9K in option awards, $170.7K in stock awards and $52.2K in other compensation.

Rankings

In 2021, John C. McKew's compensation ranked 7,559th out of 12,415 executives tracked by ExecPay. In other words, McKew earned more than 39.1% of executives.

ClassificationRankingPercentile
All
7,559
out of 12,415
39th
Division
Manufacturing
3,328
out of 5,505
40th
Major group
Chemicals And Allied Products
1,475
out of 2,375
38th
Industry group
Drugs
1,313
out of 2,096
37th
Industry
Pharmaceutical Preparations
969
out of 1,546
37th
Source: SEC filing on March 23, 2022.

McKew's colleagues

We found two more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2021.

2021

Richard Hawkins

NewLink Genetics

Chief Executive Officer

2021

Lori Lawley

NewLink Genetics

Chief Financial Officer

News

You may also like